BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/03/1994

Opportunity For Licensing: Calanolide Antiviral Compounds as Antiviral Agents Useful in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)

The National Institutes of Health (NIH) is seeking a licensee to develop calanolide A or related anti-viral compounds for treating human immunodeficiency virus (HIV) infection, with the goal of treating Acquired Immunodeficiency Syndrome (AIDS).

Source: Federal Register — Health and Human ServicesOpen original release →